当前位置： SCI文献检索 > Orphanet Journal of Rare Diseases期刊下所有文献 > Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease.

Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease.

Abstract：

:Taliglucerase alfa is an enzyme replacement therapy (ERT) approved for treatment of adult and paediatric patients with Type 1 Gaucher disease (GD) in several countries and the first plant cell-expressed recombinant therapeutic protein approved by the US Food and Drug Administration for humans. Here, we review the findings across six key taliglucerase alfa clinical studies. A total of 33 treatment-naïve adult patients were randomized to taliglucerase alfa 30 U/kg or 60 U/kg in a 9-month, multicentre, randomized, double-blind, parallel-group, dose-comparison pivotal study, after which eligible patients continued into two consecutive extension studies; 17 treatment-naïve adult patients completed 5 total years of treatment with taliglucerase alfa. In the only ERT study focused on exclusively paediatric patients with GD, 11 treatment-naïve children were randomized to taliglucerase alfa 30 U/kg or 60 U/kg in a 12-month, multicentre, double-blind study; nine completed 3 total years of treatment in a dedicated paediatric extension study. The effect of switching patients from imiglucerase to taliglucerase alfa was also investigated in a separate 9-month study that included 26 adults and five children; 10 adults completed a total of 3 years and two children completed a total of 2.75 years of taliglucerase alfa treatment in the extension studies. All studies evaluated safety and spleen volume, liver volume, platelet count, haemoglobin concentration, and biomarkers as measures of efficacy. Detailed results from baseline through the end of these studies are presented. Taliglucerase alfa was well tolerated, and adverse events were generally mild/moderate in severity and transient. Treatment with taliglucerase alfa resulted in improvements (treatment-naïve patients) or stability (patients switched from imiglucerase) in visceral, haematologic, and biomarker parameters. Together, this comprehensive data set supports the treatment of adult and paediatric patients with GD who are naïve to ERT or who have previously been treated with imiglucerase.

journal_name

Orphanet J Rare Dis

journal_title

Orphanet journal of rare diseases

authors

Zimran A,Wajnrajch M,Hernandez B,Pastores GM

doi

10.1186/s13023-018-0776-8

subject

Has Abstract

pub_date

2018-02-23 00:00:00

pages

36

issue

1

issn

1750-1172

pii

10.1186/s13023-018-0776-8

journal_volume

13

pub_type

杂志文章,评审

相关文献

Orphanet Journal of Rare Diseases文献大全
  • How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration.

    abstract：:Among the challenges confronting patients with rare diseases is a dearth of treatment options. The development of safe and effective new therapies is hampered by challenges associated with conducting clinical trials in small populations. In this article, we describe how the Duchenne muscular dystrophy community-led by...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-015-0281-2

    authors： Furlong P,Bridges JF,Charnas L,Fallon JR,Fischer R,Flanigan KM,Franson TR,Gulati N,McDonald C,Peay H,Sweeney HL

    更新日期：2015-06-24 00:00:00

  • Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis.

    abstract：BACKGROUND:The clinical course of Cystic Fibrosis (CF) is usually measured using the percent predicted FEV(1) and BMI Z-score referenced against a healthy population, since achieving normality is the ultimate goal of CF care. Referencing against age and sex matched CF peers may provide valuable information for patients...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/1750-1172-7-64

    authors： Boëlle PY,Viviani L,Busson PF,Olesen HV,Ravilly S,Stern M,Assael BM,Barreto C,Drevinek P,Thomas M,Krivec U,Mei-Zahav M,Vibert JF,Clement A,Mehta A,Corvol H,French CF Modifier Gene Study Investigators.,European CF Regist

    更新日期：2012-09-07 00:00:00

  • Hereditary angioedema due to C1 - inhibitor deficiency in Switzerland: clinical characteristics and therapeutic modalities within a cohort study.

    abstract：BACKGROUND:Registration of trigger factors, prodromal symptoms, swelling localization, therapeutic behavior and gender-specific differences of the largest cohort of patients with hereditary angioedema due to C1-Inhibitor deficiency (C1-INH-HAE) in Switzerland. METHODS:Questionnaire survey within a cohort study: Consen...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-016-0423-1

    authors： Steiner UC,Weber-Chrysochoou C,Helbling A,Scherer K,Grendelmeier PS,Wuillemin WA

    更新日期：2016-04-21 00:00:00

  • The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.

    abstract：:The hyper-IgE syndromes are rare, complex primary immunodeficiencies characterized by clinical manifestation diversity, by particular susceptibility to staphylococcal and mycotic infections as well as by a heterogeneous genetic origin. Two distinct entities--the classical hyper-IgE syndrome which is inherited in an au...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,评审

    doi：10.1186/1750-1172-6-76

    authors： Szczawinska-Poplonyk A,Kycler Z,Pietrucha B,Heropolitanska-Pliszka E,Breborowicz A,Gerreth K

    更新日期：2011-11-15 00:00:00

  • Preferential expression of mutant ABCD1 allele is common in adrenoleukodystrophy female carriers but unrelated to clinical symptoms.

    abstract：BACKGROUND:Approximately 20% of adrenoleukodystrophy (X-ALD) female carriers may develop clinical manifestations, typically consisting of progressive spastic gait, sensory deficits and bladder dysfunctions. A skewing in X Chromosome Inactivation (XCI), leading to the preferential expression of the X chromosome carrying...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/1750-1172-7-10

    authors： Salsano E,Tabano S,Sirchia SM,Colapietro P,Castellotti B,Gellera C,Rimoldi M,Pensato V,Mariotti C,Pareyson D,Miozzo M,Uziel G

    更新日期：2012-01-26 00:00:00

  • Future treatments for hereditary hemorrhagic telangiectasia.

    abstract：:Hereditary Hemorrhagic Telangiectasia (HHT), also known as Rendu-Osler syndrome, is a genetic vascular disorder affecting 1 in 5000-8000 individuals worldwide. This rare disease is characterized by various vascular defects including epistaxis, blood vessel dilations (telangiectasia) and arteriovenous malformations (AV...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,评审

    doi：10.1186/s13023-019-1281-4

    authors： Robert F,Desroches-Castan A,Bailly S,Dupuis-Girod S,Feige JJ

    更新日期：2020-01-07 00:00:00

  • Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics.

    abstract：BACKGROUND:The aim of our study is to study the association between eye lesions in Hereditary Hemorrhagic Telangiectasia (HHT) and other signs of the disease, as well as to characterize its genetics. METHODS:A cross-sectional study was conducted of a cohort of 206 patients studied in the HHT Unit of Hospital de Sierra...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-020-01433-5

    authors： Gómez-Acebo I,Prado SR,De La Mora Á,Puente RZ,de la Roza Varela B,Dierssen-Sotos T,Llorca J

    更新日期：2020-06-29 00:00:00

  • Impact of Friedreich's Ataxia on health-care resource utilization in the United Kingdom and Germany.

    abstract：BACKGROUND:Friedreich's Ataxia (FRDA) is a neurodegenerative disorder that causes progressive damage to the central and peripheral nervous systems having a significant impact upon quality of life. With little information in the literature, cross-sectional observational studies were conducted in the UK and Germany to co...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/1750-1172-8-38

    authors： Giunti P,Greenfield J,Stevenson AJ,Parkinson MH,Hartmann JL,Sandtmann R,Piercy J,O'Hara J,Casas LR,Smith FM

    更新日期：2013-02-28 00:00:00

  • miR-411 is up-regulated in FSHD myoblasts and suppresses myogenic factors.

    abstract：BACKGROUND:Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant muscle disorder, which is linked to the contraction of the D4Z4 array at chromosome 4q35. Recent studies suggest that this shortening of the D4Z4 array leads to aberrant expression of double homeobox protein 4 (DUX4) and causes FSHD. In a...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/1750-1172-8-55

    authors： Harafuji N,Schneiderat P,Walter MC,Chen YW

    更新日期：2013-04-05 00:00:00

  • Family burden in inherited ichthyosis: creation of a specific questionnaire.

    abstract：BACKGROUND:The concept of individual burden, associated with disease, has been introduced recently to determine the "disability" caused by the pathology in the broadest sense of the word (psychological, social, economic, physical). Inherited ichthyosis belong to a large heterogeneous group of Mendelian Disorders of Cor...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/1750-1172-8-28

    authors： Dufresne H,Hadj-Rabia S,Méni C,Sibaud V,Bodemer C,Taïeb C

    更新日期：2013-02-15 00:00:00

  • Incidence of inherited metabolic disorders in southern Israel: a comparison between consanguinity and non-consanguinity communities.

    abstract：BACKGROUND:Inherited metabolic disorders (IMDs) are group of rare monogenic diseases, usually derived from reduced or absent activity in a single metabolic pathway. Most of the IMDs are inherited in an autosomal recessive manner. The incidence of IMDs varies from country to country and within different ethnic groups, b...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-020-01578-3

    authors： Hazan G,Hershkovitz E,Staretz-Chacham O

    更新日期：2020-11-25 00:00:00

  • Determinants of impaired quality of life in patients with fibrous dysplasia.

    abstract：BACKGROUND:Fibrous dysplasia is a rare bone disorder, commonly associated with pain, deformity and fractures, which may significantly impact on quality of life. In this study we evaluate quality of life in patients with fibrous dysplasia using the Short Form-36 and the Brief Pain Inventory questionnaires. Data were com...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-017-0629-x

    authors： Majoor BCJ,Andela CD,Bruggemann J,van de Sande MAJ,Kaptein AA,Hamdy NAT,Dijkstra PDS,Appelman-Dijkstra NM

    更新日期：2017-04-27 00:00:00

  • Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD).

    abstract：BACKGROUND:LCHADD is a long-fatty acid oxidation disorder with immediate symptoms and long-term complications. We evaluated data on clinical status, biochemical parameters, therapeutic regimens and outcome of Austrian LCHADD patients. STUDY DESIGN:Clinical and outcome data including history, diagnosis, short- and long...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-015-0236-7

    authors： Karall D,Brunner-Krainz M,Kogelnig K,Konstantopoulou V,Maier EM,Möslinger D,Plecko B,Sperl W,Volkmar B,Scholl-Bürgi S

    更新日期：2015-02-22 00:00:00

  • The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis.

    abstract：:In 1963, five cases of alpha1-antitrypsin deficiency were reported in the scientific literature, as well as an attempt to treat pulmonary alveolar proteinosis by a massive washing of the lung (whole lung lavage). Now, fifty years later, it seems the ideal moment not only to commemorate these publications, but also to ...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,评审

    doi：10.1186/1750-1172-8-153

    authors： Trapnell BC,Luisetti M

    更新日期：2013-09-30 00:00:00

  • European lipodystrophy registry: background and structure.

    abstract：BACKGROUND:Lipodystrophy syndromes comprise a group of extremely rare and heterogeneous diseases characterized by a selective loss of adipose tissue in the absence of nutritional deprivation or catabolic state. Because of the rarity of each lipodystrophy subform, research in this area is difficult and international co-...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-020-1295-y

    authors： von Schnurbein J,Adams C,Akinci B,Ceccarini G,D'Apice MR,Gambineri A,Hennekam RCM,Jeru I,Lattanzi G,Miehle K,Nagel G,Novelli G,Santini F,Santos Silva E,Savage DB,Sbraccia P,Schaaf J,Sorkina E,Tanteles G,Vantyghem MC

    更新日期：2020-01-15 00:00:00

  • Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR.

    abstract：BACKGROUND:It has been suggested that ultra-rare diseases should be recognized as distinct from more prevalent rare diseases, but how drugs developed to treat ultra-rare diseases (DURDs) might be distinguished from drugs for 'other' rare diseases (DORDs) is not clear. We compared the characteristics of DURDs to DORDs f...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,评审

    doi：10.1186/s13023-018-0762-1

    authors： Richter T,Janoudi G,Amegatse W,Nester-Parr S

    更新日期：2018-02-01 00:00:00

  • A nationwide survey on Marinesco-Sjögren syndrome in Japan.

    abstract：BACKGROUND:Marinesco-Sjögren syndrome (MSS) is an autosomal recessive multisystem disorder characterized by the tetralogy of cerebellar ataxia, congenital cataracts, intellectual disability, and progressive muscle weakness due to myopathy. MSS is extremely rare, and its clinical, pathological, and genetic features are ...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/1750-1172-9-58

    authors： Goto M,Okada M,Komaki H,Sugai K,Sasaki M,Noguchi S,Nonaka I,Nishino I,Hayashi YK

    更新日期：2014-04-23 00:00:00

  • Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?

    abstract：:Since its enactment in 2000, the European Orphan Medicinal Products Regulation has allowed the review and approval of approaching 70 treatments for some 55 different conditions in Europe. Success does not come without a price, however. Many of these so-called "orphan drugs" have higher price points than treatments for...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/1750-1172-7-74

    authors： Hughes-Wilson W,Palma A,Schuurman A,Simoens S

    更新日期：2012-09-26 00:00:00

  • Correction to: Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies.

    abstract：:An amendment to this paper has been published and can be accessed via the original article. ...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,已发布勘误

    doi：10.1186/s13023-020-01464-y

    authors： Opladen T,López-Laso E,Cortès-Saladelafont E,Pearson TS,Sivri HS,Yildiz Y,Assmann B,Kurian MA,Leuzzi V,Heales S,Pope S,Porta F,García-Cazorla A,Honzík T,Pons R,Regal L,Goez H,Artuch R,Hoffmann GF,Horvath G,Thöny B

    更新日期：2020-08-05 00:00:00

  • Juvenile xanthogranuloma as a new type of skin lesions in tuberous sclerosis complex.

    abstract：OBJECTIVE:Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disease with many manifestations, and it involves any organ. In this study, we report a TSC patient with new type skin lesions. METHODS:A 7-month-old TSC boy with multiple cutaneous nodules was admitted in our hospital. We collected the cl...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-020-01396-7

    authors： Lu Q,Shi XY,Wang YY,Zhang MN,Wang WZ,Wang J,Wang QH,Chen HM,Zou LP

    更新日期：2020-06-12 00:00:00

  • Xeroderma pigmentosum-Cockayne syndrome complex.

    abstract：:Xeroderma pigmentosum-Cockayne syndrome complex is a very rare multisystem degenerative disorder (Orpha: 220295; OMIM: 278730, 278760, 278780, 610651). Published information on XP-CS is mostly scattered throughout the literature. We compiled statistics related to symptom prevalence in XP-CS and have written a clinical...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,评审

    doi：10.1186/s13023-017-0616-2

    authors： Natale V,Raquer H

    更新日期：2017-04-04 00:00:00

  • Incidence, disease onset and short-term outcome in urea cycle disorders -cross-border surveillance in Germany, Austria and Switzerland.

    abstract：BACKGROUND:Urea cycle disorders (UCDs) are a group of rare inherited metabolic disorders. Affected individuals often present with hyperammonemic encephalopathy (HE) and have an increased risk of severe neurologic disease and early death. The study aims to provide epidemiologic data and to describe the disease manifesta...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-017-0661-x

    authors： Nettesheim S,Kölker S,Karall D,Häberle J,Posset R,Hoffmann GF,Heinrich B,Gleich F,Garbade SF,Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen (APS); European registry and network for Intoxication type Metabolic Diseases (E-IM

    更新日期：2017-06-15 00:00:00

  • Sickle cell disease induces resistance to cutaneous carcinogenesis.

    abstract：BACKGROUND:While skin carcinomas are reported in chronic ulcers and in patients treated with hydroxyurea (HU) for myeloproliferative neoplasms, no skin carcinoma has been reported in patients with sickle cell disease (SCD), presenting chronic skin ulcers or treated with HU. The objective was to estimate the risk of cut...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-020-1341-9

    authors： Soutou B,Senet P,Lionnet F,Habibi A,Aractingi S

    更新日期：2020-03-06 00:00:00

  • Neuropsychological and neuroanatomical phenotype in 17 patients with cystinosis.

    abstract：BACKGROUND:Cystinosis is a rare autosomal recessive disorder caused by intracellular cystine accumulation. Proximal tubulopathy (Fanconi syndrome) is one of the first signs, leading to end-stage renal disease between the age of 12 and 16. Other symptoms occur later and encompass endocrinopathies, distal myopathy and de...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-019-1271-6

    authors： Curie A,Touil N,Gaillard S,Galanaud D,Leboucq N,Deschênes G,Morin D,Abad F,Luauté J,Bodenan E,Roche L,Acquaviva C,Vianey-Saban C,Cochat P,Cotton F,Bertholet-Thomas A

    更新日期：2020-02-26 00:00:00

  • A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome.

    abstract：BACKGROUND:Rare diseases are individually rare but globally affect around 6% of the population, and in over 70% of cases are genetically determined. Their rarity translates into a delayed diagnosis, with 25% of patients waiting 5 to 30 years for one. It is essential to raise awareness of patients and clinicians of exis...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-020-01493-7

    authors： Atalaia A,Thompson R,Corvo A,Carmody L,Piscia D,Matalonga L,Macaya A,Lochmuller A,Fontaine B,Zurek B,Hernandez-Ferrer C,Rheinard C,Gómez-Andrés D,Desaphy JF,Schon K,Lohmann K,Jennings MJ,Synofzik M,Riess O,Yaou RB,

    更新日期：2020-08-12 00:00:00

  • Rapamycin and its analogues (rapalogs) for Tuberous Sclerosis Complex-associated tumors: a systematic review on non-randomized studies using meta-analysis.

    abstract：BACKGROUND:Rapamycin has gained significant attention for its potential activity in reducing the size of TSC-associated tumors, thus providing alternative to surgery. This study aimed at determining the efficacy of rapamycin and rapalogs for reducing the size of TSC-associated solid tumors in patients with Tuberous Scl...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,meta分析,评审

    doi：10.1186/s13023-015-0317-7

    authors： Sasongko TH,Ismail NF,Nik Abdul Malik NM,Zabidi-Hussin ZA

    更新日期：2015-08-12 00:00:00

  • Sensory and motor neuronopathy in a patient with the A382P TDP-43 mutation.

    abstract：:Patients with TARDBP mutations have so far been classified as ALS, sometimes with frontal lobe dysfunction. A 66-year-old patient progressively developed a severe sensory disorder, followed by a motor disorder, which evolved over nine years. Symptoms started in the left hand and slowly involved the four limbs. Investi...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/1750-1172-6-4

    authors： Camdessanché JP,Belzil VV,Jousserand G,Rouleau GA,Créac'h C,Convers P,Antoine JC

    更新日期：2011-02-05 00:00:00

  • Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature.

    abstract：BACKGROUND:Lysosomal storage disorders (LSD) are a rare cause of non immunological hydrops fetalis (NIHF) and congenital ascites. The reported incidence is about 1%. The incidence of idiopathic NIHF is estimated to be about 18%. PATIENTS AND METHODS:We report four cases with transient hydrops fetalis resulting from LS...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,评审

    doi：10.1186/1750-1172-7-86

    authors： Whybra C,Mengel E,Russo A,Bahlmann F,Kampmann C,Beck M,Eich E,Mildenberger E

    更新日期：2012-11-08 00:00:00

  • Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency.

    abstract：BACKGROUND:The activation of plasma enzyme systems contributes to hereditary angioedema attacks. We aimed to study the activation markers of the fibrinolytic, coagulation, and contact systems in a larger number of paired samples obtained from the same C1-INH-HAE patients in symptom-free periods and during attacks. MET...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-015-0351-5

    authors： Csuka D,Veszeli N,Imreh É,Zotter Z,Skopál J,Prohászka Z,Varga L,Farkas H

    更新日期：2015-10-09 00:00:00

  • Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.

    abstract：BACKGROUND:Infants presenting with lysosomal acid lipase deficiency have marked failure to thrive, diarrhea, massive hepatosplenomegaly, anemia, rapidly progressive liver disease, and death typically in the first 6 months of life; the only available potential treatment has been hematopoietic stem cell transplantation, ...

    journal_title：Orphanet journal of rare diseases

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1186/s13023-017-0587-3

    authors： Jones SA,Rojas-Caro S,Quinn AG,Friedman M,Marulkar S,Ezgu F,Zaki O,Gargus JJ,Hughes J,Plantaz D,Vara R,Eckert S,Arnoux JB,Brassier A,Le Quan Sang KH,Valayannopoulos V

    更新日期：2017-02-08 00:00:00